A phase I study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary clinical activity of MEDI0562 in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) Meeting Abstract
| Authors: | Leidner, R. S.; Patel, S. P.; Fury, M. G.; Ferris, R. L.; McDevitt, J. T.; Lanasa, M. C.; Glisson, B. S. |
| Abstract Title: | A phase I study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary clinical activity of MEDI0562 in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) |
| Meeting Title: | Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904809 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.tps6083 |
| Notes: | Meeting Abstract: TPS6083 -- Source: Wos |
